Patents by Inventor Bernd Schnabl

Bernd Schnabl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligosaccharide as therapeutic agent for alcohol associated liver disease
    Patent number: 11896603
    Abstract: The disclosure provides for the use of an oligosaccharide for the treatment of liver disease. More particularly, the disclosure provide methods and composition for treating liver disease comprising administering 2?-FL to a subject.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: February 13, 2024
    Assignee: The Regents of the University of California
    Inventors: Lars Bode, Bernd Schnabl
  • OLIGOSACCHARIDE AS THERAPEUTIC AGENT FOR ALCOHOL ASSOCIATED LIVER DISEASE
    Publication number: 20210386765
    Abstract: The disclosure provides for the use of an oligosaccharide for the treatment of liver disease. More particularly, the disclosure provide methods and composition for treating liver disease comprising administering 2?-FL to a subject.
    Type: Application
    Filed: June 11, 2021
    Publication date: December 16, 2021
    Inventors: Lars Bode, Bernd Schnabl
  • BIOMARKER AND TREATMENT TARGET FOR ALCOHOLIC HEPATITIS
    Publication number: 20210095327
    Abstract: Methods of detecting and monitoring the progression of liver disease, including time to death, and methods of treating liver disease, in a mammal are provided.
    Type: Application
    Filed: March 28, 2019
    Publication date: April 1, 2021
    Inventors: Bernd Schnabl, Ana Cristina Llorente Izquierdo